Response to "Nerve conduction studies support the classification of SARSCoV-2 associated Guillain-Barre subtypes"
- PMID: 35600133
- PMCID: PMC9111700
- DOI: 10.1111/cen3.12696
Response to "Nerve conduction studies support the classification of SARSCoV-2 associated Guillain-Barre subtypes"
Keywords: COVID‐19 vaccines; ChAdOx1 COVID‐19 vaccine; Guillain‐Barre syndrome; peripheral nervous system diseases.
Conflict of interest statement
None declared.
References
LinkOut - more resources
Full Text Sources